All Posts:vaccine development
-
Georgetown Professor Comments on FDA Authorization of Vaccine to Prevent COVID-19
WASHINGTON (December 11, 2020) — This evening, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the BioNTech/Pfizer vaccine. Former FDA Chief Scientist and infectious disease physician Jesse Goodman, MD, MPH, professor of medicine at Georgetown University Medical Center, celebrates and provides a brief perspective on this historic moment: “The first emergency use authorization […]
Category: News Release
-
Top Vaccine Experts Join Forces to Provide Objective Perspective and Analysis as COVID-19 Vaccine Data Emerge
The COVID-19 Vaccine Analysis Team (COVAT) also offers weekly media availability. WASHINGTON (October 12, 2020) — At a time of growing skepticism about COVID-19 vaccines, an ensemble of some of America’s most trusted vaccine scientific experts has launched the COVID-19 Vaccine Analysis Team, or COVAT, to provide rapid and objective expert analysis and communications on […]
Category: News Release
-
Public Health Physicians: Four Measures Needed to Ensure Public Trust, Safety in COVID-19 Vaccine Development
WASHINGTON (July 6, 2020) — Public health experts are outlining four key safeguards necessary during the development of a COVID-19 vaccine that will ensure the public can trust that an approved vaccine is safe and effective. Writing in JAMA, the trio say that while vaccine development is moving at unprecedented speed, a growing movement of […]
Category: News Release